Resources | Association for Accessible Medicines

Applauding Nomination of Dr. Scott Gottlieb to Lead the FDA

Oct 11, 2018 | Rachel Schwartz

AAM Statement on FDA Record Generic Approvals

New NAFTA - Proposed US-Mexico-Canada Agreement (USMCA)

Oct 9, 2018 | Jeff Francer

Op-Ed: The New NAFTA Could Thwart President's Promise to Lower Prescription Drug Costs

Direct Relief and AAM - Generic Prescriptions, AAM Member

Oct 4, 2018 | Rachel Schwartz

Prescription for Hope: AAM and Direct Relief

New NAFTA - Proposed US-Mexico-Canada Agreement (USMCA)

Oct 1, 2018 | Rachel Schwartz

AAM Opposes Barriers to Generic Drug and Biosimilar Access in Proposed US-Mexico-Canada Agreement (USMCA)

New NAFTA - North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Sep 26, 2018 | Erica Klinger

Preserve Patient Access in NAFTA 2.0

Sep 24, 2018 | Rachel Schwartz

Dana Mariani Joins AAM as Director, Policy

Sep 21, 2018 | Michael Brzica

$13.4 Billion a Year! Brand “Shenanigans” Are Costing Patients More Than Ever

Sep 21, 2018 | Erica Klinger

Lost Prescription Drug Savings in the U.S.

Sep 20, 2018 | Rachel Schwartz

AAM Statement on CBO CREATES Score

Ariel Leaty, cancer patient, generic drug savings

Sep 20, 2018 | Erica Klinger

Generic Prescriptions Save Lives… and Money, Too

Video

Sep 19, 2018 | Erica Klinger

Generic Drugs Are the Prescription for Savings. Don't Take Them for Granted.

FDA's Competitive Generic Therapy (CGT) Designation

Sep 19, 2018 | Erica Klinger

10 Takeaways from the Savings Report